FPH.NZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 08:00):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...

Stats
Dzisiejszy wolumen	207 235
Średni wolumen	412 053
Kapitalizacja rynkowa	16.88B
EPS	NZD0 ( 2023-11-28 )
Następna data zysków	( NZD0 ) 2024-05-23
Last Dividend	NZD0 ( N/A )
Next Dividend	NZD0 ( N/A )
P/E	64.22
ATR14	NZD0.0160 (0.06%)

Wolumen Korelacja

Długi: -0.06 (neutral)

Krótki: -0.05 (neutral)

Signal:(55.174) Neutral

Fisher & Paykel Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fisher & Paykel Korelacja - Waluta/Towar

-0.76
( moderate negative )

-0.77
( moderate negative )

0.00
( neutral )

-0.84
( strong negative )

0.84
( strong )

Fisher & Paykel Finanse

Annual	2023
Przychody:	NZD1.59B
Zysk brutto:	NZD945.90M (59.54 %)
EPS:	NZD0.430

FY	2023
Przychody:	NZD1.59B
Zysk brutto:	NZD945.90M (59.54 %)
EPS:	NZD0.430

FY	2022
Przychody:	NZD1.64B
Zysk brutto:	NZD1.01B (61.70 %)
EPS:	NZD0.650

Financial Reports:

No articles found.

Fisher & Paykel

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.